KCT0002244招募中未知
A phase I clinical trial to investigate the safety, tolerability, and pharmacokinetics/pharmacodynamics of Tripegfilgrastim after single administration in pediatric solid tumor/lymphoma patients
Dong-A ST0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 6(Year) 至 18(Year)（—）
- 性别
- All
入选标准
- •>=6 and <19 year-old pediatrics with solid tumor/lymphoma • Scheduled for chemotherapy requiring G-CSF support or having given an experience of ANC> < 0.5 x 10^9/L
- •ANC > 0.75 x 10^9/L, platelet > 75 x 10^9/L
- •ECOG performance status 0 or 1
排除标准
- •Patients with leukemia, myelodysplastic syndrome or uncontrolled infectious/nervous diseases
- •History of allergy to filgrastim, pegfilgrastim or known hypersensitivity to E-coli derived proteins
- •Women who are pregnant or lactating
研究者
相似试验
未知
1 期
A Phase I clinical trial to investigate the safety and tolerability of NK105 when co-administered with carboplatin once per week to Japanese patients with advanced solid cancers.Advanced solid cancersJPRN-jRCT2080223202ippon Kayaku Co., Ltd.18
招募中
1 期
Cell Therapy for back paiCTRI/2024/07/069696Samarthakrupa LIfesciences Pvt Ltd
进行中（未招募）
1 期
A Phase I clinical trial to assess the safety and immunogenicity of HIV DNA immunisations administered via the Intramuscular and Intradermal methods with and without electroporation followed by boosting with recombinant HIV protein in healthy male and female volunteersHIV prophylaxisMedDRA version: 18.0 Level: PT Classification code 10020161 Term: HIV infection System Organ Class: 10021881 - Infections and infestationsEUCTR2015-001023-23-GBImperial College London28
进行中（未招募）
1 期
A dendritic cell vaccine to suppress the immune response to citrullinated antigen in rheumatoid arthritisRheumatoid arthritisACTRN12610000373077niquest18
已完成
1 期
A Phase I clinical trial to evaluate the safety and pharmacokinetics of SHR0302 base ointment at single dose and multiple dose in healthy adult subjectsAtopic dermatitisSkin - Dermatological conditionsACTRN12619001443189Reistone Biopharma Co., Ltd.32